Ceftazidime-Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae

被引:10
作者
Ding, Li [1 ,2 ]
Shen, Siquan [1 ,2 ]
Han, Renru [1 ,2 ]
Yin, Dandan [1 ,2 ]
Guo, Yan [1 ,2 ]
Hu, Fupin [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200040, Peoples R China
[2] Minist Hlth, Key Lab Clin Pharmacol Antibiot, Shanghai 200040, Peoples R China
来源
ANTIBIOTICS-BASEL | 2022年 / 11卷 / 05期
基金
中国国家自然科学基金;
关键词
KPC-2; KPC-33; ceftazidime-avibactam; imipenem; RESISTANCE; EMERGENCE;
D O I
10.3390/antibiotics11050604
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A 22-year-old man, after a hematopoietic stem cell transplant, suffered long-term pneumonia caused by bla(KPC-2)-positive K. pneumoniae and bla(KPC-33-)positive K. pneumoniae alternately and finally achieved pathogenic clearance and improvement of clinical infectious conditions after using ceftazidime-avibactam in combination with imipenem as salvage therapy. This case provides a reference for treating infection caused by K. pneumoniae with a KPC variant in countries lacking new antimicrobial agents.
引用
收藏
页数:6
相关论文
共 15 条
  • [1] Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
    Ben-David, D.
    Kordevani, R.
    Keller, N.
    Tal, I.
    Marzel, A.
    Gal-Mor, O.
    Maor, Y.
    Rahav, G.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (01) : 54 - 60
  • [2] Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature
    Cano, Angela
    Guzman-Puche, Julia
    Garcia-Gutierrez, Manuel
    Jose Caston, Juan
    Gracia-Ahufinger, Irene
    Perez-Nadales, Elena
    Recio, Manuel
    Natera, Alejandra M.
    Marfil-Perez, Eduardo
    Martinez-Martinez, Luis
    Torre-Cisneros, Julian
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 9 - 12
  • [3] Comparison of Four Carbapenemase Detection Methods for blaKPC-2 Variants
    Ding, Li
    Shi, Qingyu
    Han, Renru
    Yin, Dandan
    Wu, Shi
    Yang, Yang
    Guo, Yan
    Zhu, Demei
    Hu, Fupin
    [J]. MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [4] In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
    Gaibani, Paolo
    Campoli, Caterina
    Lewis, Russell E.
    Volpe, Silvia Lidia
    Scaltriti, Erika
    Giannella, Maddalena
    Pongolini, Stefano
    Berlingeri, Andrea
    Cristini, Francesco
    Bartoletti, Michele
    Tedeschi, Sara
    Ambretti, Simone
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (06) : 1525 - 1529
  • [5] Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates
    Giddins, Marla J.
    Macesic, Nenad
    Annavajhala, Medini K.
    Stump, Stephania
    Khan, Sabrina
    McConville, Thomas H.
    Mehta, Monica
    Gomez-Simmonds, Angela
    Uhlemann, Anne-Catrin
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
  • [6] Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
    Goettig, Stephan
    Frank, Denia
    Mungo, Eleonora
    Nolte, Anika
    Hogardt, Michael
    Besier, Silke
    Wichelhaus, Thomas A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (11) : 3211 - 3216
  • [7] In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae
    Hackel, Meredith A.
    Lomovskaya, Olga
    Dudley, Michael N.
    Karlowsky, James A.
    Sahm, Daniel F.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [8] Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology
    Lasko, Maxwell J.
    Nicolau, David P.
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2020, 22 (03)
  • [9] Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri
    Lebreton, Francois
    Corey, Brendan W.
    McElheny, Christi L.
    Iovleva, Alina
    Preston, Lan
    Margulieux, Katie R.
    Cybulski, Robert J.
    Mc Gann, Patrick
    Doi, Yohei
    Bennett, Jason W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (07)
  • [10] Emergence and Recovery of Ceftazidime-avibactam Resistance in blaKPC-33-Harboring Klebsiella pneumoniae Sequence Type 11 Isolates in China
    Shi, Qingyu
    Yin, Dandan
    Han, Renru
    Guo, Yan
    Zheng, Yonggui
    Wu, Shi
    Yang, Yang
    Li, Shirong
    Zhang, Rong
    Hu, Fupin
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 : S436 - S439